HealthRevolution Medicines wins EU committee backing for pancreatic cancer drug
A European Medicines Agency committee recommended on Thursday that the EU approve a Revolution Medicines drug for adults with metastatic pancreatic cancer. It could provide a new option for patients facing a disease with few effective treatments.
R
Reuters★★★☆☆2026-10-15 19:05Original
Revolution Medicines wins EU committee backing for pancreatic cancer drug
Health